FCSDX
Price
$19.77
Change
-$0.09 (-0.45%)
Updated
Aug 20 closing price
Net Assets
5.8B
NSOIX
Price
$20.88
Change
+$0.11 (+0.53%)
Updated
Aug 21 closing price
Net Assets
155.1M
Interact to see
Advertisement

FCSDX vs NSOIX

FCSDX vs NSOIX Comparison Chart in %
View a ticker or compare two or three
VS
FCSDX vs. NSOIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCSDX is a Hold and NSOIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FCSDX has more cash in the bank: 5.8B vs. NSOIX (155M). FCSDX (1.26) and NSOIX (1.23) have matching dividends . FCSDX was incepted earlier than NSOIX: FCSDX (23 years) vs NSOIX (15 years). FCSDX (1.67) is less costly to investors than NSOIX (1.38). FCSDX is a more actively managed with annual turnover of: 41.00 vs. NSOIX (25.00). FCSDX has a lower initial minimum investment than NSOIX: FCSDX (0) vs NSOIX (5000). NSOIX annual gain was more profitable for investors over the last year : 22.70 vs. FCSDX (13.64). FCSDX return over 5 years is better than : 18.07 vs. NSOIX (15.34).
FCSDXNSOIXFCSDX / NSOIX
Total Expense Ratio1.671.31127%
Annual Report Gross Expense Ratio1.671.38121%
Fund Existence23 years15 years-
Gain YTD14.21815.22293%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.8B155M3,741%
Annual Yield % from dividends1.261.23102%
Returns for 1 year13.6422.7060%
Returns for 3 years34.0339.4686%
Returns for 5 years18.0715.34118%
Returns for 10 years49.9194.5353%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIEMX58.580.79
+1.37%
Driehaus Emerging Markets Growth Instl
ANTGX11.820.14
+1.20%
American Century Non-US Intrs Val G
RWIBX81.530.67
+0.83%
American Funds Cptl Wld Gr&Inc R-2
TGVYX58.300.26
+0.45%
Touchstone Dynamic Large Cap Growth Y
MUSBX40.970.18
+0.44%
MFS Blended Research Core Equity B